- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/08 - Bronchodilators
Patent holdings for IPC class A61P 11/08
Total number of patents in this class: 599
10-year publication summary
|
28
|
17
|
17
|
24
|
32
|
50
|
44
|
42
|
23
|
16
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 940 |
30 |
| AstraZeneca AB | 3042 |
28 |
| Almirall, S.A. | 534 |
12 |
| Boehringer Ingelheim International GmbH | 4629 |
10 |
| Daiichi Sankyo Company, Limited | 1829 |
10 |
| Theravance Biopharma R&D IP, LLC | 550 |
9 |
| Bayer AG | 3045 |
8 |
| Vertex Pharmaceuticals Incorporated | 1581 |
8 |
| Pulmagen Therapeutics (Synergy) Limited | 21 |
8 |
| Glaxo Group Limited | 4496 |
7 |
| Cipla Limited | 469 |
7 |
| Shionogi & Co., Ltd. | 914 |
7 |
| Novartis AG | 11238 |
6 |
| Bayer Pharma AG | 1096 |
6 |
| Takeda Pharmaceutical Company Limited | 2961 |
6 |
| Almirall Prodesfarma S.A. | 6 |
6 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 616 |
6 |
| Dainippon Sumitomo Pharma Co., Ltd. | 234 |
6 |
| Nippon Shinyaku Co., Ltd. | 297 |
6 |
| Respiratorius AB | 13 |
6 |
| Other owners | 407 |